Literature DB >> 10857890

Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer.

T Nozoe1, T Matsumata, K Sugimachi.   

Abstract

The significance of a preoperative elevation of serum C-reactive protein (CRP) as an indicator of the malignant potential and prognosis in colorectal cancer is reported. The reduction of circulating lymphocytes reflects the immunosuppressive conditions of patients with neoplasms. The aim of the current study was to elucidate the significance of a preoperative elevation of serum CRP as an indicator of the impaired immunity of the patients with colorectal cancer. The subjects were 155 consecutive patients with colorectal cancer who were treated with surgical resection. The preoperative serum CRP level and the proportion of circulating lymphocytes in peripheral blood were measured and the relationship between these values was investigated. The mean value of lymphocytes percentages in patients with the preoperative elevation of serum CRP was 25.2 +/- 8.7%, which was significantly lower than that (33.4 +/- 9.3%) in patients without the preoperative elevation of serum CRP (p < 0.01). In summary, preoperative elevation of serum CRP was significantly related to the reduction of lymphocyte percentages in peripheral blood, and it can be an indicator of impaired immunity in the patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857890     DOI: 10.1097/00000421-200006000-00011

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  26 in total

1.  Preoperative inflammation increases the risk of infection after elective colorectal surgery: results from a prospective cohort.

Authors:  Luigi De Magistris; Brice Paquette; David Orry; Olivier Facy; Giovanni Di Giacomo; Patrick Rat; Christine Binquet; Pablo Ortega-Deballon
Journal:  Int J Colorectal Dis       Date:  2016-06-29       Impact factor: 2.571

2.  Usefulness of an inflammation-based prognostic score (mGPS) for predicting survival in patients with unresectable malignant biliary obstruction.

Authors:  Yoshimi Iwasaki; Mitsuru Ishizuka; Masato Kato; Junji Kita; Mitsugi Shimoda; Keiichi Kubota
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

3.  Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery.

Authors:  Koichiro Mori; Yuji Toiyama; Susumu Saigusa; Hiroyuki Fujikawa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.

Authors:  Tadahiro Nozoe; Rumi Matono; Hideki Ijichi; Takefumi Ohga; Takahiro Ezaki
Journal:  Int Surg       Date:  2014 Sep-Oct

5.  Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma.

Authors:  Tadahiro Nozoe; Mizuki Ninomiya; Takashi Maeda; Akito Matsukuma; Hideaki Nakashima; Takahiro Ezaki
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

6.  High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer.

Authors:  Judit Kocsis; Tamás Mészáros; Balázs Madaras; Eva Katalin Tóth; Szilárd Kamondi; Péter Gál; Lilian Varga; Zoltán Prohászka; George Füst
Journal:  Cell Stress Chaperones       Date:  2010-08-22       Impact factor: 3.667

7.  Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.

Authors:  Yuji Toiyama; Chikao Miki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

8.  Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Authors:  Kyung A Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Jin-Yeong Han; Kyeong Hee Kim; Ri Young Goh; Hong Jo Choi; Ki Jae Park; Mee Sook Roh; Hyo-Jin Kim; Hyuk-Chan Kwon; Jong Hoon Lee
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

9.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma.

Authors:  Tadahiro Nozoe; Emiko Mori; Ikuo Takahashi; Takahiro Ezaki
Journal:  Surg Today       Date:  2008-07-09       Impact factor: 2.549

Review 10.  Perioperative host-tumor inflammatory interactions: a potential trigger for disease recurrence following a curative resection for colorectal cancer.

Authors:  Chikao Miki; Kouji Tanaka; Yasuhiro Inoue; Toshimitsu Araki; Masaki Ohi; Yasuhiko Mohri; Keiichi Uchida; Masato Kusunoki
Journal:  Surg Today       Date:  2008-07-09       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.